Skip to content
U.S. Anti-Doping Agency        Athletes:    Login Help
FacebookTwitterYouTubeLinkedinInstagram
  • English
UFC Anti-Doping Program
UFC Anti-Doping Program
  • About
    • Annual Report
    • Board of Directors
    • Contact
    • Meet Our Team
  • Science
  • Testing
    • Sample Collection Process
    • Therapeutic Use Exemptions
    • Whereabouts
    • Retirement Responsibilities
    • Results Management
    • Athlete Test History
    • Sanctions
    • Testing Numbers
  • Substances
    • WADA Prohibited List
    • Therapeutic Use Exemptions
    • UFC Global DRO
    • Drug Reference Phone Line
    • Effects of Performance-Enhancing Drugs
    • Marijuana FAQ
  • Supplements
  • Resources
    • Publications & Policies
    • Frequently Asked Questions
    • Play Clean Tip Center
    • Athlete Express
  • News & Media
  • Athlete’s Corner
    • #FollowMyLead
  • USADA
 
  • About
    • Annual Report
    • Board of Directors
    • Contact
    • Meet Our Team
  • Science
  • Testing
    • Sample Collection Process
    • Therapeutic Use Exemptions
    • Whereabouts
    • Retirement Responsibilities
    • Results Management
    • Athlete Test History
    • Sanctions
    • Testing Numbers
  • Substances
    • WADA Prohibited List
    • Therapeutic Use Exemptions
    • UFC Global DRO
    • Drug Reference Phone Line
    • Effects of Performance-Enhancing Drugs
    • Marijuana FAQ
  • Supplements
  • Resources
    • Publications & Policies
    • Frequently Asked Questions
    • Play Clean Tip Center
    • Athlete Express
  • News & Media
  • Athlete’s Corner
    • #FollowMyLead
  • USADA

Monthly Archives: May 2016

You are here:
  1. Home
  2. 2016
  3. May

UFC Athlete, Brandao, Accepts Sanction for Anti-Doping Rule Violation

SanctionsBy Betsy DouglasMay 19, 2016

May 19, 2016 USADA announced today that Diego Brandao, of São Paulo, Brazil, tested positive for a prohibited substance and has accepted a nine-month sanction for his anti-doping policy violation. Brandao, 28, tested positive for Carboxy-THC, a metabolite of marijuana and/or hashish, above the decision limit of 180 ng/mL, stemming from an in-competition sample collected…

  • Careers
  • Copyright
  • Organizational Documents
  • Privacy Statement
  • Usage Policy
Bottom
Go to Top